Novotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., . . . Davies, P. (2011). A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. European journal of neurology, 18(9), 1122-1131. https://doi.org/10.1111/j.1468-1331.2010.03328.x
Citácia podle Chicago (17th ed.)Novotna, A., et al. "A Randomized, Double-blind, Placebo-controlled, Parallel-group, Enriched-design Study of Nabiximols (Sativex®), as Add-on Therapy, in Subjects with Refractory Spasticity Caused by Multiple Sclerosis." European Journal of Neurology 18, no. 9 (2011): 1122-1131. https://doi.org/10.1111/j.1468-1331.2010.03328.x.
Citácia podľa MLA (8th ed.)Novotna, A., et al. "A Randomized, Double-blind, Placebo-controlled, Parallel-group, Enriched-design Study of Nabiximols (Sativex®), as Add-on Therapy, in Subjects with Refractory Spasticity Caused by Multiple Sclerosis." European Journal of Neurology, vol. 18, no. 9, 2011, pp. 1122-1131, https://doi.org/10.1111/j.1468-1331.2010.03328.x.